Evolva revokes 2023 guidance and considers “strategic transactions” in light of financing negotiations

14 Jun 2023 — Swiss biotech player Evolva is looking at strategic transactions, including a potential sale of the company, after entering into negotiations with its financing partner, Nice & Green. The discussions involve a different interpretation of the company’s financing terms per the financier.